Diligent’s BoardEffect software user base scales to more than triple the size of any other board software provider focused on nonprofits
NEW YORK -Friday 14 January 2022 [ AETOS Wire ]
(BUSINESS WIRE)-- Diligent, the global leader in modern governance providing SaaS solutions across governance, risk, compliance and ESG, today announces incredibly strong year-over-year growth for its mission-driven business, resulting in more than 8,500 clients across public sector, community healthcare, primary education and nonprofit entities globally. Due to the pandemic, nearly every organization has had to bring their leadership and governance online, and as a result, Diligent’s BoardEffect software, a board management solution optimized for nonprofit organizations, has been implemented by nearly triple the boards and committees of any other provider focused on that sector.
Since 2017, Diligent has delivered collaboration tools and technology that enable publi
...
Read more »
|
Hemingway charged with driving SES’s growth strategy
LUXEMBOURG-Tuesday 18 January 2022 [ AETOS Wire ]
(BUSINESS WIRE) -- SES is adding a new Chief Strategy and Product Officer (CSPO) to its Senior Leadership Team, underscoring SES’s commitment to ideate, build and deliver the services and solutions that create the most value for SES customers and partners, as well as their end-users.
John-Paul (JP) Hemingway is charged with translating SES's corporate vision into strategic action for the company's networks and video markets – including its target applications, strategic partnerships, portfolio of solutions, and the space and network assets required to deliver them. The newly-created function brings together the Corporate Strategy, Product, Commercial Operations, Fleet Development, Innovation and Marketing & Communications teams, and is part of SES’s drive to be the most customer-centric, product-led or
...
Read more »
|
BiologyWorks k(now)™ Handheld Molecular Testing Device Among the Most Accurate for COVID-19
LOS ANGELES-Tuesday 18 January 2022 [ AETOS Wire ]
(BUSINESS WIRE) -- BiologyWorks™, Inc., a digital healthcare platform company, today announced that a substantive clinical trial of its handheld, reusable molecular test for COVID-19 matched 99.1% accuracy to laboratory RT-PCR tests.
The independent clinical trial, conducted by Locus Medicus in Athens, Greece, prospectively tested 330 patients with symptomatic and asymptomatic cases of COVID-19. For the study, staff at the clinical laboratory collected two bilateral anterior nasal swabs from each patient. Immediately after collection, one swab was tested in the lab’s standard of care CE-Mark RT-PCR test and the other swab was tested by BiologyWorks k(now). Results from the BiologyWorks k(now) molecular test were 99.1% in overall percent agreement with the results of the RT-PCR lab tests
...
Read more »
|
Megaport’s partnership with the global IT distributor and solutions aggregator enables enterprises to accelerate their digital and network transformation
BRISBANE, Australia & CLEARWATER, Fla.-Tuesday 18 January 2022 [ AETOS Wire ]
(BUSINESS WIRE)-- Megaport Limited (ASX: MP1) ("Megaport"), a global leading Network as a Service (NaaS) provider, today announces a partnership with TD SYNNEX, a global IT distributor and solutions aggregator, to make Megaport’s global, private Software Defined Network (SDN) platform available to TD SYNNEX customers.
“Bringing Megaport’s leading Network as a Service platform into the TD SYNNEX portfolio makes it easier for customers to modernize their network connectivity and connect quickly to leading cloud service providers,” said Rodney Foreman, Chief Revenue Officer at Megaport. “TD
...
Read more »
|
LAGOS, Nigeria-Tuesday 18 January 2022 [ AETOS Wire ]
(BUSINESS WIRE) -- Africa Finance Corporation, Africa’s leading infrastructure solutions provider, has raised USD$400 million in a new syndicated loan to support the post-pandemic recovery through critical development of infrastructure.
The three-year facility – the first from AFC since 2018 – was increased from an initial target of USD$300 million as strong interest from investors led to the offering being 2.5 times oversubscribed. The proceeds will facilitate upcoming infrastructure projects that address the continent’s developmental challenges.
“The transaction demonstrates the confidence of banking partners, both old and new, in AFC’s strong credit risk profile and broadening global appeal in the capital markets,” said Banji Fehintola, Senior Director & Treasurer at AFC. “This loan will be instrumental in working towards plugging the infrastructure ga
...
Read more »
|
Dubai, United Arab Emirates-Tuesday 18 January 2022 [ AETOS Wire ]
His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President, Prime Minister and Ruler of Dubai, presented awards to the 10 winners of the 2022 Zayed Sustainability Prize yesterday.
The Prize’s Awards Ceremony coincided with the start of the 2022 Abu Dhabi Sustainability Week (ADSW). The ceremony was also attended by H.H. Sheikh Maktoum bin Mohammed bin Rashid Al Maktoum, Deputy Ruler of Dubai, Deputy Prime Minister and Minister of Finance.
His Highness Sheikh Mohammed bin Rashid Al Maktoum congratulated winners across the five categories reaffirming the Prize’s key role in realising the aspirations of participants to achieve sustainable development within their communities.
This year, the Zayed Sustainability Prize, along with ADSW, joined forces with Expo 2020 Dubai for hosting the ADSW Opening Ceremony and the 13th edition of the Prize’s Awards Ceremony, both
...
Read more »
|
MELBOURNE, Australia & ST. GALLEN, Switzerland-Tuesday 18 January 2022 [ AETOS Wire ]
(BUSINESS WIRE) -- Regulatory News:
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
CSL Behring AG, Berne, Switzerland, a wholly-owned subsidiary of global biotechnology leader CSL Limited (ASX: CSL; USOTC: CSLLY), today published the offer prospectus regarding its public tender offer for all publicly held registered shares of Vifor Pharma Ltd. (SIX:VIFN; ISIN:CH0364749348), a global specialty pharmaceutical company with leadership in Iron Deficiency, Nephrology & Cardio-Renal Therapies, as indicated in the pre-announcement of the public tender offer published by CSL Limited on 14 December 2021.
The transaction, has been unanimously approved by both companies’ Boards of Directors. The offer price for each registered share of Vifor Pharma Ltd. is USD 179.25 in cash. The public tender offer is subject to the offer conditions set forth in the offer prospectus,
...
Read more »
|
|